Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

China flag China · Delayed Price · Currency is CNY
8.32
+0.09 (1.09%)
At close: Mar 10, 2026
-16.72%
Market Cap 5.49B
Revenue (ttm) 257.74M
Net Income (ttm) -220.75M
Shares Out 659.74M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,799,500
Average Volume 7,439,304
Open 8.23
Previous Close 8.23
Day's Range 8.23 - 8.46
52-Week Range 5.69 - 11.67
Beta 0.39
RSI 59.24
Earnings Date Apr 29, 2026

About SHE:002581

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. The company is involved in the chemical raw materials, chemical product manufacturing, and biopharmaceutical manufacturing; production and sales of medicines. It also offers operating chemical products, such as trimethyl ester and triethyl ester. The company was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd. [Read more]

Sector Healthcare
Founded 2000
Employees 476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002581
Full Company Profile

Financial Performance

In 2024, SHE:002581's revenue was 360.41 million, a decrease of -16.14% compared to the previous year's 429.79 million. Losses were -137.31 million, -58.70% less than in 2023.

Financial Statements

News

There is no news available yet.